Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  D DERMATOLOGICALS
    D10 ANTI-ACNE PREPARATIONS
      D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
        D10AD Retinoids for topical use in acne
          D10AD01 Tretinoin [DG:DG00433]
            D00094  Tretinoin (JAN/USP/INN) <JP/US>
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01X OTHER ANTINEOPLASTIC AGENTS
        L01XF Retinoids for cancer treatment
          L01XF01 Tretinoin [DG:DG00433]
            D00094  Tretinoin (JAN/USP/INN) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Retinoids
      Tretinoin [DG:DG00433]
        D00094  Tretinoin (JAN/USP/INN)
  Dermatological Agents
    Acne and Rosacea Agents
      Retinoids
        Tretinoin [DG:DG00433]
          D00094  Tretinoin (JAN/USP/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  4  Agents affecting cellular function
    42  Antineoplastics
      429  Miscellaneous
        4291  Other Antitumors
          D00094  Tretinoin (JAN/USP/INN)

Drug groups [BR:br08330]
  Vitamin and mineral
    DG01604  Retinol derivative
      DG00433  Tretinoin
        D00094  Tretinoin

Target-based classification of drugs [BR:br08310]
  Nuclear receptors
    Thyroid hormone like receptors
      Retinoic acid receptor (RAR)
        NR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]
          D00094  Tretinoin (JAN/USP/INN) <JP/US>
        PML-RARA [HSA:5371 5914] [KO:K10054 K08527]
          D00094  Tretinoin (JAN/USP/INN) <JP/US>